Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients
Titel:
Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients
Auteur:
Costa, Luisa Caso, Francesco Atteno, Mariangela Puente, Antonio Del Darda, Md Abud Caso, Paolo Ortolan, Augusta Fiocco, Ugo Ramonda, Roberta Punzi, Leonardo Scarpa, Raffaele